共 46 条
- [34] Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma Annals of Hematology, 2021, 100 : 2745 - 2754
- [36] Re: Which Better Predicts Mortality among Older Men, a Prostate Cancer (PCa) Diagnosis or Vulnerability on the Vulnerable Elders Survey (VES-13)? A Retrospective Cohort Study Editorial Comment JOURNAL OF UROLOGY, 2017, 198 (04): : 723 - 724